Incomplete rather than complete nasolacrimal duct obstruction Is strongly associated with meibomian gland dysfunction in postmenopausal women with PANDO: a cross-sectional study - Summary - MDSpire

Incomplete rather than complete nasolacrimal duct obstruction Is strongly associated with meibomian gland dysfunction in postmenopausal women with PANDO: a cross-sectional study

  • By

  • Haili Jin

  • Yin Liu

  • Xianjie Chen

  • April 30, 2026

  • 0 min

Share

Objective:

To identify and assess key demographic, clinical, and hormonal factors associated with meibomian gland dysfunction (MGD) in postmenopausal women with primary acquired nasolacrimal duct obstruction (PANDO), highlighting the significance of MGD in this context.

Key Findings:
  • Include context on the implications of incomplete obstruction and its association with MGD severity.
Interpretation:

Expand on the clinical implications of incomplete PANDO contributing to MGD.

Limitations:
  • Provide specific examples of potential confounding factors that may not have been fully accounted for.
Conclusion:

Emphasize the importance of routine meibography for early detection of MGD in postmenopausal women with PANDO.

Original Source(s)

Incomplete rather than complete nasolacrimal duct obstruction Is strongly associated with meibomian gland dysfunction in postmenopausal women with PANDO: a cross-sectional study

  • by Haili Jin, Yin Liu, Xianjie Chen

  • April 30, 2026

Related Content

Getting to the Root of Dry Eye Symptom Management With Nutrition

Learn how the Standard American Diet impacts dry eye disease and discover evidence-based supplementation strategies to improve ocular surface damage and DED.

Biocompatibility and Contact Lens Wear

In this feature, Alex Hui, OD, PhD, looks at the research and determines that contact lenses could be considered one of the most successful examples of biocompatible devices used. He further examines contact lens dropout and how to achieve contact lens wear success.

Prescribing for Dry Eye Disease

The Tear Film and Ocular Surface Society (TFOS) Dry Eye Workshop (DEWS) III report, which was recently released, includes an updated prescribing algorithm based on DED etiology or pathogenic drivers.